Penyusutan dan Penurunan Nisbah C/N pada Vermicomposting Campuran Feses Sapi Perah dan Jerami Padi menggunakan Eisenia fetida

Penelitian ini bertujuan untuk mengetahui tingkat penyusutan dan penurunan nisbah C/N padavermicompostingcampuran feses sapi perah dan jerami padi menggunakan Eisenia fetida.  Penelitian dilaksanakan dengan menggunakan metode Rancangan Acak Lengkap (RAL).  Perlakuan yang diberikan adalah tiga perlakuan nisbah C/N yakni :   25  (T1), 30 (T2), dan 35 (T3).  Proses diawali dengan dekomposisi awal selama 7 hari, kemudian dilanjutkan dengan vermicompostingselama 15 hari.    Data dianalisis melalui sidik ragam dan untuk mengetahui perbedaan antar perlakuan dilakukan uji Duncan.  Hasil penelitian menunjukkan bahwa : (1) Penyusutan selama dekomposisi awal berkisar antara 20,5 – 28,8 % dengan nisbah C/N mencapai 15,5-17,5. (2) Penyusutan selama vermicompostingberkisar antara 52,35 – 60,50 % dengan nisbah C/N mencapai 10,5 – 11,0.  

Right subclavian double steal syndrome: a case report

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Displaced distal forearm fractures in children with an indication for reduction under general anesthesia should be percutaneously fixated

Surger

Distal radius fractures in children: substantial difference in stability between buckle and greenstick fractures

Background and purpose Numerous follow-up visits for wrist fractures in children are performed without therapeutic consequences. We investigated the degree to which the follow-up visits reveal complications and lead to change in management. The stability of greenstick and buckle fractures of the distal radius was assessed by comparing the lateral angulation radiographically

Renin‐Angiotensin‐Aldosterone System Inhibitors Are Associated With Favorable Outcomes Compared to Beta Blockers in Reducing Mortality Following Abdominal Aneurysm Repair

Background The best medical therapy to control hypertension following abdominal aortic aneurysm repair is yet to be determined. We therefore examined whether treatment with renin-angiotensin-aldosterone system inhibitors (RAASIs) versus beta blockers influenced postoperative and 1-year clinical end points following abdominal aortic aneurysm repair in a Medicare-linked database. Methods and Results All patients with hypertension undergoing endovascular aneurysm repair and open aneurysm repair in the Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network database between 2003 and 2018 were included. Patients were divided into 2 groups based on their preoperative and discharge medications, either RAASIs or beta blockers. Our cohort included 8789 patients, of whom 3523 (40.1%) were on RAASIs, and 5266 (59.9%) were on beta blockers. After propensity score matching, there were 3053 matched pairs of patients in each group. After matching, RAASI use was associated with lower risk of postoperative mortality (odds ratio [OR], 0.3 [95% CI, 0.1-0.6]), myocardial infarction (OR, 0.1 [95% CI, 0.03-0.6]), and nonhome discharge (OR, 0.6 [95% CI, 0.5-0.7]). Before propensity score matching, RAASI use was associated with lower 1-year mortality (hazard ratio [HR], 0.4 [95% CI, 0.4-0.5]) and lower risk of aneurysmal rupture (HR, 0.7 [95% CI, 0.5-0.9]). These results persisted after propensity score matching for mortality (HR, 0.4 [95% CI, 0.4-0.5]) and aneurysmal rupture (HR, 0.7 [95% CI, 0.5-0.9]). Conclusions In this large contemporary retrospective cohort study, RAASI use was associated with favorable postoperative outcomes compared with beta blockers. It was also associated with lower mortality and aneurysmal rupture at 1 year of follow-up

Renin‐Angiotensin‐Aldosterone System Inhibitors Are Associated With Favorable Outcomes Compared to Beta Blockers in Reducing Mortality Following Abdominal Aneurysm Repair

Background The best medical therapy to control hypertension following abdominal aortic aneurysm repair is yet to be determined. We therefore examined whether treatment with renin‐angiotensin‐aldosterone system inhibitors (RAASIs) versus beta blockers influenced postoperative and 1‐year clinical end points following abdominal aortic aneurysm repair in a Medicare‐linked database. Methods and Results All patients with hypertension undergoing endovascular aneurysm repair and open aneurysm repair in the Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network database between 2003 and 2018 were included. Patients were divided into 2 groups based on their preoperative and discharge medications, either RAASIs or beta blockers. Our cohort included 8789 patients, of whom 3523 (40.1%) were on RAASIs, and 5266 (59.9%) were on beta blockers. After propensity score matching, there were 3053 matched pairs of patients in each group. After matching, RAASI use was associated with lower risk of postoperative mortality (odds ratio [OR], 0.3 [95% CI, 0.1–0.6]), myocardial infarction (OR, 0.1 [95% CI, 0.03–0.6]), and nonhome discharge (OR, 0.6 [95% CI, 0.5–0.7]). Before propensity score matching, RAASI use was associated with lower 1‐year mortality (hazard ratio [HR], 0.4 [95% CI, 0.4–0.5]) and lower risk of aneurysmal rupture (HR, 0.7 [95% CI, 0.5–0.9]). These results persisted after propensity score matching for mortality (HR, 0.4 [95% CI, 0.4–0.5]) and aneurysmal rupture (HR, 0.7 [95% CI, 0.5–0.9]). Conclusions In this large contemporary retrospective cohort study, RAASI use was associated with favorable postoperative outcomes compared with beta blockers. It was also associated with lower mortality and aneurysmal rupture at 1 year of follow‐up